Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic

Ann Rheum Dis. 2021 Jan;80(1):26-30. doi: 10.1136/annrheumdis-2020-219217. Epub 2020 Oct 14.

Kim Lauper^{1

2}, Johannes W J Bijlsma³, Gerd R Burmester⁴

¹ Division of Rheumatology, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland Kim.Lauper@hcuge.ch.
² Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, UK.
³ Department of Rheumatology and Clinical Immunology, UMC Utrecht, Utrecht, Netherlands.
⁴ Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Freie Universitität und Humboldt-University Berlin, Berlin, Germany.

No abstract available

Keywords: antirheumatic agents; biological therapy; communicable diseases; hydroxychloroquine; imported.

Publication types